Dr. Lim is a Consultant Endocrinologist and Head of the Diabetes Care Unit, University of Malaya, Kuala Lumpur, Malaysia. As a clinician-scientist, Dr. Lim’s major areas of interest are cardiometabolic medicine with translational and implementation science components.

She sits on the Scientific Work Groups of the American Diabetes Association/European Association for the Study of Diabetes Precision Medicine in Diabetes Initiative (ADA/EASD PMDI) and The Lancet Commission on Diabetes, who provide authoritative resources in tackling the global diabetes epidemic. She has published ~100 peer-reviewed articles including high-impact journals such as The Lancet, Nature, Diabetes Care, and Science Bulletin.

Dr. Lim has received several awards including the World’s Top 2% Scientists by Stanford University for 2 Consecutive years in 2022 and 2023, the European Foundation for the Study of Diabetes (EFSD) Albert Renold Fellowship, and the USA Endocrine Society Outstanding Abstract Award. She is an Editorial Board Member of several Tier 1 Web of Science-indexed journals (BMC Medicine, Diabetes/Metabolism Research & Reviews, and Diabetes & Metabolism journal). She is also the Vice President of the Malaysian Osteoporosis Society and Honorary Asst Secretary of the Malaysian Endocrine and Metabolic Society (MEMS).